×
Bayer Total Long-Term Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
Bayer Total Long-Term Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$861.2B
Novo Nordisk (NVO)
$526.5B
Johnson & Johnson (JNJ)
$392B
AbbVie (ABBV)
$329.5B
Merck (MRK)
$269.3B
AstraZeneca (AZN)
$240.1B
Novartis AG (NVS)
$236.6B
Pfizer (PFE)
$163.9B
Sanofi (SNY)
$136.2B
Innoviva (INVA)
$1.2B